Haemostatic factors in women with history of Preeclampsia

Thrombosis Research

Volumn 124, Issue 1, 2009, Pages 52-56

  Portelinha, Ana ^a   Cerdeira, Ana Sofia ^b   Belo, Luís ^a,c   Braga, Jorge ^b   Tejera, Eduardo ^c   Pinto, Ana ^d   Pinto, Fátima ^d   José Areias, Maria ^d   Patrício, Belmiro ^c   Rebelo, Irene ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d NONE   (Portugal)

Author keywords

Cardiovascular disease; D dimer; PAI 1; Preeclampsia; t PA, fibrinogen, haemostatic factors

Indexed keywords

ANTIGEN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; AUTOMATION; BLOOD LEVEL; CAPILLARY ZONE ELECTROPHORESIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; METHODOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; THROMBOSIS;

ADULT; CASE-CONTROL STUDIES; DIMERIZATION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEMOSTASIS; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRE-ECLAMPSIA; PREGNANCY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 64649099777     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.10.005     Document Type: Article

References (46)

1. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
2. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
3. Harnett M.J., Datta S., and Bhavani-Shankar K. The effect of magnesium on coagulation in parturients with preeclampsia. Anesth Analg 92 5 (May 2001) 1257-1260
4. Lam C., Lim K.H., and Karumanchi S.A. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46 5 (Nov 2005) 1077-1085
5. Walker J.J. Pre-eclampsia. Lancet 356 9237 (Oct 7 2000) 1260-1265
6. Bellamy L., Casas J.P., Hingorani A.D., and Williams D.J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335 7627 (Nov 10 2007) 974
7. Smith G.C., Pell J.P., and Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 357 9273 (Jun 23 2001) 2002-2006
8. Irgens H.U., Reisaeter L., Irgens L.M., and Lie R.T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 323 7323 (Nov 24 2001) 1213-1217
9. Sattar N., and Greer I.A. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. BMJ 325 7356 (Jul 20 2002) 157-160
10. Hannaford P., Ferry S., and Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart 77 2 (Feb 1997) 154-158
11. Jonsdottir L.S., Arngrimsson R., Geirsson R.T., Sigvaldason H., and Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 74 10 (Nov 1995) 772-776
12. Halligan A., Bonnar J., Sheppard B., Darling M., and Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol 101 6 (Jun 1994) 488-492
13. González-Quintero V.H., Jiménez J.J., Jy W., Mauro L.M., Hortman L., O'Sullivan M.J., and Ahn Y. Elevated plasma endothelial microparticles in preeclampsia. Am J Obstet Gynecol 189 2 (Aug 2003) 589-593
14. Catarino C., Rebelo I., Belo L., Rocha S., Castro E.B., Patricio B., Quintanilha A., and Santos-Silva A. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies. Thromb Res (Mar 31 2008)
15. Harnett M.J., Datta S., and Bhavani-Shankar K. The effect of magnesium on coagulation in parturients with preeclampsia. Anesth Analg 92 5 (May 2001) 1257-1260
16. Kobayashi T., Tokunaga N., Sugimura M., Suzuki K., Kanayama N., Nishiguchi T., and Terao T. Coagulation/fibrinolysis disorder in patients with severe preeclampsia. Semin Thromb Hemost 25 5 (1999) 451-454
17. Belo L., Santos-Silva A., Rumley A., Lowe G., Pereira-Leite L., Quintanilha A., and Rebelo I. Elevated tissue plasminogen activator as a potential marker of endothelial dysfunction in pre-eclampsia: correlation with proteinuria. BJOG 109 11 (Nov 2002) 1250-1255
18. Bellart J., Gilabert R., Angles A., Piera V., Miralles R.M., Monasterio J., and Cabero L. Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia. Br J Obstet Gynaecol 106 6 (Jun 1999) 594-597
19. Schjetlein R., Abdelnoor M., Haugen G., Husby H., Sandset P.M., and Wisloff F. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia. Acta Obstet Gynecol Scand 78 3 (Mar 1999) 191-197
20. Agatisa P.K., Ness R.B., Roberts J.M., Costantino J.P., Kuller L.H., and McLaughlin M.K. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol 286 4 (Apr 2004) H1389-H1393
21. Eichinger S. D-dimer testing in pregnancy. Semin Vasc Med 5 4 (Nov 2005) 375-378
22. Jorgensen M., Philips M., Thorsen S., Selmer J., and Zeuthen J. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma. Thromb Haemost 58 3 (Oct 28 1987) 872-878
23. Allessi M.C., Peiretti F., Morange P., Henry M., Nalbone G., and Juhan-Vague I. Production of plasminogen activator inhibitor-1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46 (1997) 860-867
24. Eichinger S. D-dimer testing in pregnancy. Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):327-9. 16.
25. Stegnar M., Vene N., and Bozic M. Do haemostasis activation markers that predict cardiovascular disease exist?. Pathophysiol Haemost Thromb 33 5-6 (Sep-2004 Dec 2003) 302-308
26. Yin K.H., Koh S.C., Malcus P., SvenMontan S., Biswas A., Arulkumaran S., and Ratnam S.S. Preeclampsia: haemostatic status and the short-term effects of methyldopa and isradipine therapy. J Obstet Gynaecol Res 24 3 (Jun 1998) 231-238
27. Ridker P.M., Hennekens C.H., Cerskus A., and Stampfer M.J. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 90 5 (Nov 1994) 2236-2240
28. Thögersen A.M., Jansson J.H., Boman K., Nilsson T.K., Weinehall L., Huhtasaari F., and Hallmans G. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 98 21 (Nov 24 1998) 2241-2247
29. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., Rumley A., and Lowe G.D. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation 103 19 (May 15 2001) 2323-2327
30. Pradhan A.D., LaCroix A.Z., Langer R.D., Trevisan M., Lewis C.E., Hsia J.A., Oberman A., Kotchen J.M., and Ridker P.M. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women. Circulation 110 3 (Jul 20 2004) 292-300
31. Folsom A.R., Aleksic N., Park E., Salomaa V., Juneja H., and Wu K.K. Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 21 4 (Apr 2001) 611-617
32. Lowe G.D., Rumley A., Sweetnam P.M., Yarnell J.W., and Rumley J. Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the caerphilly study. Thromb Haemost 86 3 (Sep 2001) 822-827
33. Lowe G.D., Sweetnam P.M., Yarnell J.W., Rumley A., Rumley C., Bainton D., and Ben- Shlomo Y. C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies. Arterioscler Thromb Vasc Biol 24 10 (Oct 2004) 1957-1962
34. Vickers M., Ford I., Morrison R., Prescott G., Watson S., Hannaford P., Smith C., Campbell D., and Greaves M. Markers of endothelial activation and atherothrombosis in women with history of preeclampsia or gestational hypertension. Thromb Haemost 90 6 (Dec 2003) 1192-1197
35. Roberts J.M. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16 1 (1998) 5-15
36. Roberts J.M., and Hubel C.A. Is oxidative stress the link in the two-stage model of preeclampsia?. Lancet 354 9181 (Sep 4 1999) 788-789
37. Estellés A., Gilabert J., Aznar J., Loskutoff D.J., and Schleef R.R. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood 74 4 (Sep 1989) 1332-1338
38. Estellés A., Gilabert J., España F., Aznar J., and Galbis M. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. Am J Obstet Gynecol 165 1 (Jul 1991) 138-142
39. Friedman S.A., Schiff E., Emeis J.J., Dekker G.A., and Sibai B.M. Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol 172 1 Pt 1 (Jan 1995) 202-203
40. Wakai A., Gleeson A., and Winter D. Role of fibrin D-dimer testing in emergency medicine. Emerg Med J 20 4 (Jul 2003) 319-325
41. Branch D.W., and Porter T.F. Hypertensive disorders of pregnancy. In: Scott J.R., Saia P.J.D., Hammond C.B., and Spellacy W.N. (Eds). Danforth's obstetrics & gynecology. 8th ed. (1999), Lippincott Williams &Wilkins, Philadelphia 309-326
42. Sibai B.M. Hypertension. In: Gabbe S.G., Niebyl J.R., and Simpson J.L. (Eds). Obstetrics: normal and problem pregnancies. 4th ed. (2002), Churchill Livingstone, Philadelphia 945-1004
43. Berends A.L., de Groot C.J., Sijbrands E.J., Sie M.P., Benneheij S.H., Pal R., Heydanus R., Oostra B.A., van Duijn C.M., and Steegers E.A. Shared constitutional risks for maternal vascularrelated pregnancy complications and future cardiovascular disease. Hypertension 51 4 (Apr 2008) 1034-1041
44. Pieper C.F., Rao K.M., Currie M.S., Harris T.B., and Chen H.J. Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons. J Gerontol A Biol Sci Med Sci 55 11 (Nov 2000) M649-M657
45. Lee A.J., Fowkes G.R., and Lowe G.D. Rumley A.Determinants of fibrin D-dimer in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 15 8 (Aug 1995) 1094-1097
46. Vaziri N.D., Smith D.H., Winer R.L., Weber M.A., Gonzales E.C., and Neutel J.M. Coagulation and inhibitory and fibrinolytic proteins in essential hypertension. J Am Soc Nephrol 4 2 (Aug 1993) 222-228